Single, Fixed-Dose Intranasal Ketamine for Alleviation of Acute Suicidal Ideation. An Emergency Department, Trans-Diagnostic Approach: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial

References

• Bahr, R., Lopez, A., & Rey, J. A. (2019). Intranasal esketamine (Spravato(TM)) for use in treatment-resistant depression in conjunction with an oral antidepressant. P T, 44(6), 340–375.
   PubMedGoogle Scholar
• Ballard, E. D., Ionescu, D. F., Vande Voort, J. L., Niciu, M. J., Richards, E. M., Luckenbaugh, D. A., … Zarate, C. A. Jr. (2014). Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety. Journal of Psychiatric Research, 58, 161–166. doi:10.1016/j.jpsychires.2014.07.027
   PubMed Web of Science ®Google Scholar
• Ballard, E. D., Luckenbaugh, D. A., Richards, E. M., Walls, T. L., Brutsche, N. E., Ameli, R., … Zarate, C. A. Jr. (2015). Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant. Journal of Psychiatric Research, 68, 68–73. doi:10.1016/j.jpsychires.2015.06.003
   PubMed Web of Science ®Google Scholar
• Beck, A. T., Steer, R. A., & Ranieri, W. F. (1988). Scale for suicide ideation: Psychometric properties of a self-report version. Journal of Clinical Psychology, 44(4), 499–505. doi:10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6
   PubMed Web of Science ®Google Scholar
• Brent, D. A. (2016). Antidepressants and Suicidality. The Psychiatric Clinics of North America, 39(3), 503–512. doi:10.1016/j.psc.2016.04.002. 27514302
   PubMed Web of Science ®Google Scholar
• Burger, J., Capobianco, M., Lovern, R., Boche, B., Ross, E., Darracq, M. A., & McLay, R. (2016). A double-blinded, randomized, placebo-controlled sub-dissociative dose ketamine pilot study in the treatment of acute depression and suicidality in a military emergency department setting. Military Medicine, 181(10), 1195–1199. doi:10.7205/MILMED-D-15-00431
   PubMed Web of Science ®Google Scholar
• Canuso, C. M., Singh, J. B., Fedgchin, M., Alphs, L., Lane, R., Lim, P., … Drevets, W. C. (2018). Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: Results of a double-blind, randomized, placebo-controlled study. American Journal of Psychiatry, 175(7), 620–630. doi:10.1176/appi.ajp.2018.17060720
   PubMed Web of Science ®Google Scholar
• Daly, E. J., Singh, J. B., Fedgchin, M., Cooper, K., Lim, P., Shelton, R. C., … Drevets, W. C. (2018). Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: A randomized clinical trial. JAMA Psychiatry, 75(2), 139–148. doi:10.1001/jamapsychiatry.2017.3739
   PubMed Web of Science ®Google Scholar
• Diazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., … Zarate, C. A. Jr. (2010). A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Archives of General Psychiatry, 67(8), 793–802. doi:10.1001/archgenpsychiatry.2010.90
   PubMed Web of Science ®Google Scholar
• Domany, Y., Bleich-Cohen, M., Tarrasch, R., Meidan, R., Litvak-Lazar, O., Stoppleman, N., … Sharon, H. (2018). Repeated oral ketamine for out-patient treatment of resistant depression: Randomised, double-blind, placebo-controlled, proof-of-concept study. British Journal of Psychiatry, 214(1), 20–27. doi:10.1192/bjp.2018.196
   PubMed Web of Science ®Google Scholar
• Domany, Y., Shelton, R. C., & McCullumsmith, C. B. (2020). Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double-blind, placebo-controlled, proof-of-concept trial. Depression and Anxiety, 37(3), 224–233. doi:10.1002/da.22975
   PubMed Web of Science ®Google Scholar
• Fu, D. J., Ionescu, D. F., Li, X., Lane, R., Lim, P., Sanacora, G., … Canuso, C. M. (2020). Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: Double-blind, randomized study (ASPIRE I). The Journal of Clinical Psychiatry, 81(3), 19m13191. doi:10.4088/JCP.19m13191
   PubMed Web of Science ®Google Scholar
• Galvez, V., Li, A., Huggins, C., Glue, P., Martin, D., Somogyi, A. A., … Loo, C. K. (2018). Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial. Journal of Psychopharmacology, 32(4), 397–407. doi:10.1177/0269881118760660
   PubMed Web of Science ®Google Scholar
• Griffiths, J. J., Zarate, C. A., Jr., & Rasimas, J. J. (2014). Existing and novel biological therapeutics in suicide prevention. American Journal of Preventive Medicine, 47(3 Suppl 2), S195–S203. doi:10.1016/j.amepre.2014.06.012
   PubMed Web of Science ®Google Scholar
• Grunebaum, M. F., Ellis, S. P., Keilp, J. G., Moitra, V. K., Cooper, T. B., Marver, J. E., … Mann, J. J. (2017). Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial. Bipolar Disorders, 19(3), 176–183. doi:10.1111/bdi.12487
   PubMed Web of Science ®Google Scholar
• Grunebaum, M. F., Galfalvy, H. C., Choo, T. H., Keilp, J. G., Moitra, V. K., Parris, M. S., … Mann, J. J. (2018). Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. The American Journal of Psychiatry, 175(4), 327–335. doi:10.1176/appi.ajp.2017.17060647
   PubMed Web of Science ®Google Scholar
• Hoertel, N., Franco, S., Wall, M. M., Oquendo, M. A., Kerridge, B. T., Limosin, F., & Blanco, C. (2015). Mental disorders and risk of suicide attempt: A national prospective study. Molecular Psychiatry, 20(6), 718–726. doi:10.1038/mp.2015.19
   PubMed Web of Science ®Google Scholar
• Horon, R., McManus, T., Schmollinger, J., Barr, T., & Jimenez, M. (2013). A study of the use and interpretation of standardized suicide risk assessment: Measures within a psychiatrically hospitalized correctional population. Suicide & Life-Threatening Behavior, 43(1), 17–38. doi:10.1111/j.1943-278X.2012.00124.x
   PubMed Web of Science ®Google Scholar
• Ionescu, D. F., Luckenbaugh, D. A., Niciu, M. J., Richards, E. M., & Zarate, C. A. Jr. (2015). A single infusion of ketamine improves depression scores in patients with anxious bipolar depression. Bipolar Disorders, 17(4), 438–443. doi:10.1111/bdi.12277
   PubMed Web of Science ®Google Scholar
• Just, M. A., Pan, L., Cherkassky, V. L., McMakin, D., Cha, C., Nock, M. K., & Brent, D. (2017). Machine learning of neural representations of suicide and emotion concepts identifies suicidal youth. Nature Human Behaviour, 1, 911–919. doi:10.1038/s41562-017-0234-y
   PubMed Web of Science ®Google Scholar
• Kashani, P., Yousefian, S., Amini, A., Heidari, K., Younesian, S., & Hatamabadi, H. R. (2014). The effect of intravenous ketamine in suicidal ideation of emergency department patients. Emerg (Tehran), 2(1), 36–39.
   PubMedGoogle Scholar
• Kim, J., Farchione, T., Potter, A., Chen, Q., & Temple, R. (2019). Esketamine for treatment-resistant depression - first FDA-approved antidepressant in a new class. The New England Journal of Medicine, 381(1), 1–4. doi:10.1056/NEJMp1903305
   PubMed Web of Science ®Google Scholar
• Lapidus, K. A., Levitch, C. F., Perez, A. M., Brallier, J. W., Parides, M. K., Soleimani, L., … Murrough, J. W. (2014). A randomized controlled trial of intranasal ketamine in major depressive disorder. Biological Psychiatry, 76(12), 970–976. doi:10.1016/j.biopsych.2014.03.026
   PubMed Web of Science ®Google Scholar
• Le-Niculescu, H., Levey, D. F., Ayalew, M., Palmer, L., Gavrin, L. M., Jain, N., (2013). Discovery and validation of blood biomarkers for suicidality. Molecular Psychiatry, 18(12), 1249–1264. doi:10.1038/mp.2013.95
   PubMed Web of Science ®Google Scholar
• Loo, C. K., Gálvez, V., O’Keefe, E., Mitchell, P. B., Hadzi-Pavlovic, D., Leyden, J., … Glue, P. (2016). Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression. Acta Psychiatrica Scandinavica, 134(1), 48–56. doi:10.1111/acps.12572
   PubMed Web of Science ®Google Scholar
• Mallick, F., & McCullumsmith, C. B. (2016). Ketamine for treatment of suicidal ideation and reduction of risk for suicidal behavior. Current Psychiatry Reports, 18(6), 61. [pii] doi:10.1007/s11920-016-0680-7
   PubMed Web of Science ®Google Scholar
• Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. The British Journal of Psychiatry: The Journal of Mental Science, 134, 382–389. doi:10.1192/bjp.134.4.382
   PubMed Web of Science ®Google Scholar
• Murrough, J. W., Soleimani, L., DeWilde, K. E., Collins, K. A., Lapidus, K. A., Iacoviello, B. M., … Charney, D. S. (2015). Ketamine for rapid reduction of suicidal ideation: A randomized controlled trial. Psychological Medicine, 45(16), 3571–3580. doi:10.1017/S0033291715001506
   PubMed Web of Science ®Google Scholar
• Oquendo, M. A., & Baca-Garcia, E. (2014). Suicidal behavior disorder as a diagnostic entity in the DSM-5 classification system: Advantages outweigh limitations. World Psychiatry : Official Journal of the World Psychiatric Association (WPA)), 13(2), 128–130. doi:10.1002/wps.20116
   PubMed Web of Science ®Google Scholar
• Peltoniemi, M. A., Hagelberg, N. M., Olkkola, K. T., & Saari, T. I. (2016). Ketamine: A review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clinical Pharmacokinetics, 55(9), 1059–1077. doi:10.1007/s40262-016-0383-6
   PubMed Web of Science ®Google Scholar
• Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A., … Mann, J. J. (2011). The Columbia-Suicide Severity Rating Scale: Initial validity and internal consistency findings from three multisite studies with adolescents and adults. The American Journal of Psychiatry, 168(12), 1266–1277. doi:10.1176/appi.ajp.2011.10111704
   PubMed Web of Science ®Google Scholar
• Price, R. B., Iosifescu, D. V., Murrough, J. W., Chang, L. C., Al Jurdi, R. K., Iqbal, S. Z., … Mathew, S. J. (2014). Effects of ketamine on explicit and implicit suicidal cognition: A randomized controlled trial in treatment-resistant depression. Depression and Anxiety, 31(4), 335–343. doi:10.1002/da.22253
   PubMed Web of Science ®Google Scholar
• Price, R. B., Nock, M. K., Charney, D. S., & Mathew, S. J. (2009). Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biological Psychiatry, 66(5), 522–526. doi:10.1016/j.biopsych.2009.04.029
   PubMed Web of Science ®Google Scholar
• Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., … Fava, M. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163(11), 1905–1917. doi:10.1176/ajp.2006.163.11.1905
   PubMed Web of Science ®Google Scholar
• Short, B., Dong, V., Galvez, V., Vulovic, V., Martin, D., Bayes, A., … Loo, C. (2020). Development of the Ketamine Side Effect Tool (KSET). Journal of Affective Disorders, 266, 615–620. doi:10.1016/j.jad.2020.01.120
   PubMed Web of Science ®Google Scholar
• Short, B., Fong, J., Galvez, V., Shelker, W., & Loo, C. K. (2018). Side-effects associated with ketamine use in depression: A systematic review. The Lancet. Psychiatry, 5(1), 65–78. doi:10.1016/S2215-0366(17)30272-9
   PubMed Web of Science ®Google Scholar
• Singh, J. B., Fedgchin, M., Daly, E. J., De Boer, P., Cooper, K., Lim, P., … Van Nueten, L. (2016). A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. The American Journal of Psychiatry, 173(8), 816–826. doi:10.1176/appi.ajp.2016.16010037
   PubMed Web of Science ®Google Scholar
• Ting, S. A., Sullivan, A. F., Boudreaux, E. D., Miller, I., & Camargo, C. A. Jr. (2012). Trends in US emergency department visits for attempted suicide and self-inflicted injury, 1993–2008. General Hospital Psychiatry, 34(5), 557–565. doi:10.1016/j.genhosppsych.2012.03.020
   PubMed Web of Science ®Google Scholar
• Wilkinson, S. T., Ballard, E. D., Bloch, M. H., Mathew, S. J., Murrough, J. W., Feder, A., … Sanacora, G. (2018). The effect of a single dose of intravenous ketamine on suicidal ideation: A systematic review and individual participant data meta-analysis. The American Journal of Psychiatry, 175(2), 150–158. doi:10.1176/appi.ajp.2017.17040472
   PubMed Web of Science ®Google Scholar
• Witt, K., Potts, J., Hubers, A., Grunebaum, M. F., Murrough, J. W., Loo, C., … Hawton, K. (2020). Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials. The Australian and New Zealand Journal of Psychiatry, 54(1), 29–45. doi:10.1177/0004867419883341
   PubMed Web of Science ®Google Scholar
• Zarate, C. A., Jr., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., … Manji, H. K. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry, 63(8), 856–864. doi:10.1001/archpsyc.63.8.856
   PubMed Web of Science ®Google Scholar